GB642971A - Improvements in therapeutic preparations - Google Patents
Improvements in therapeutic preparationsInfo
- Publication number
- GB642971A GB642971A GB3402347A GB3402347A GB642971A GB 642971 A GB642971 A GB 642971A GB 3402347 A GB3402347 A GB 3402347A GB 3402347 A GB3402347 A GB 3402347A GB 642971 A GB642971 A GB 642971A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid
- ammonium
- toxic
- parts
- salicylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Therapeutic substances such as salicylate drugs, cincophen, amidopyrine and the sulphonamides, which ordinarily have a toxic or depressant effect on tissue metabolism or tissue respiration when adminisstered in frequent and extended dosages, are rendered non-toxic at such dosages by admixture with at least one non-toxic aliphatic, polycarboxylic acid substance of general formula R1(COOR)x where x=2 or 3; R=hydrogen, ammonium, alkali metal or alkaline earth metal; and R1 is succinic, fumaric, malic, oxalacetic, cisaconitic, isocitric or -ketoglutaric acids stripped of their carboxyl groups. The dibasic acids and in particular succinic acid, are preferred. Succinic acid and its ammonium, sodium or calcium salts are particularly effective. In one example, tablets are prepared from 3 parts of calcium succinate and 4 parts of acetylsalicylic acid. Effective compositions have 1/3 to 10 parts of calcium succinate to 1 part of acetylsalicylic acid, although a ratio of 1:1 to 3:1 is preferred. By a salicylate drug is intended salicylic acid, its esters such as ethyl salicylate, its acyl derivatives such as acetylsalicylic acid and methylene citryl salicylic acid and the ammonium, alkali and alkaline earth metal salts of such acids. Sulphathiazole and "Atebria" (R.T.M.) are other specified therapeutic substances.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3402347A GB642971A (en) | 1947-12-23 | 1947-12-23 | Improvements in therapeutic preparations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3402347A GB642971A (en) | 1947-12-23 | 1947-12-23 | Improvements in therapeutic preparations |
Publications (1)
Publication Number | Publication Date |
---|---|
GB642971A true GB642971A (en) | 1950-09-13 |
Family
ID=10360402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3402347A Expired GB642971A (en) | 1947-12-23 | 1947-12-23 | Improvements in therapeutic preparations |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB642971A (en) |
-
1947
- 1947-12-23 GB GB3402347A patent/GB642971A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES461399A1 (en) | Epinine esters and pharmaceutical compositions thereof | |
ES370058A1 (en) | Antibiotic compositions | |
GB1015787A (en) | Tris-(p-methoxyphenyl)ethylene derivatives | |
GB2000025A (en) | Nitroimidazole formulations | |
GB642971A (en) | Improvements in therapeutic preparations | |
ES353413A1 (en) | Quinoline Derivatives | |
GB739800A (en) | Aqueous pharmaceutical solutions of reserpine for parenteral administration | |
GB949523A (en) | ºÔ-(acyloxyphenoxy)-benzoic acid derivatives | |
GB972672A (en) | Pharmaceutical preparations containing compounds of the androstane series | |
GB1285858A (en) | Piperazine derivative | |
ES265597A1 (en) | Kanamycin 3-phenylsalicylate | |
JPS5283429A (en) | Preparation of aromatic unsaturated carboxylic acid amide derivatives | |
ES394344A1 (en) | Dithiocarbamic acid esters | |
IE34275B1 (en) | Alpha-hydrazino acids | |
GB1468116A (en) | Esters of 5-n-butyl-pyridine-2-carboxylic acid | |
ES369646A1 (en) | A procedure for the preparation of the derivatives of 5-thzolol carboxylic acid. (Machine-translation by Google Translate, not legally binding) | |
GB1313838A (en) | 3,4,5-trialkoxybenzoic acid derivatives and their uses | |
GB1066607A (en) | Derivatives of benzamide | |
GB905197A (en) | Anti-viral compositions comprising 1-phenyl-2-amino-propane-1,3-diol derivatives | |
GB771338A (en) | Novel antibiotically active products | |
GB1084343A (en) | ||
GB1328169A (en) | Benzamide compounds and methods for their production | |
GB1134475A (en) | Guanidine derivatives | |
GB834397A (en) | Therapeutic compositions comprising erythromycin esters | |
GB1397807A (en) | Process for preparing alpha-keto esters |